Paper41516293
miRNA in the Progression of Diabetic Kidney Disease: New Insight.
Zou Z and 2 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. miRNA in the Progression of Diabetic Kidney Disease: New Insight. Papers, record 41516293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41516293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Nephropathies | Major topic |
| MicroRNAs | Major topic |
| Humans | |
| Disease Progression | |
| Animals | |
| Biomarkers | |
| Signal Transduction | |
| Gene Expression Regulation |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82570881 | National Natural Science Foundation of China | PubMed | ||
| 82470771 | National Natural Science Foundation of China | PubMed | ||
| 82370728 | National Natural Science Foundation of China | PubMed | ||
| 82570823 | National Natural Science Foundation of China | PubMed |
Source PubMed
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24887517 | miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. | Mol Cell Endocrinol | 2014 | https://conductscience.org/library/papers/24887517 | PubMed |
| 2 | 28522654 | Diabetic Kidney Disease: Challenges, Progress, and Possibilities. | Clin J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28522654 | PubMed |
| 3 | 25182190 | Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. | BMC Nephrol | 2014 | https://conductscience.org/library/papers/25182190 | PubMed |
| 4 | 32238921 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32238921 | PubMed |
| 5 | 37138859 | MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37138859 | PubMed |
| 6 | 31447320 | Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease. | Cell Metab | 2019 | https://conductscience.org/library/papers/31447320 | PubMed |
| 7 | 37365583 | Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study. | J Hematol Oncol | 2023 | https://conductscience.org/library/papers/37365583 | PubMed |
| 8 | 32587662 | miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32587662 | PubMed |
| 9 | 27522360 | Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. | Endocrine | 2017 | https://conductscience.org/library/papers/27522360 | PubMed |
| 10 | 17786230 | MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17786230 | PubMed |
| 11 | 26898629 | Diabetic nephropathy: MiR-23b protects against fibrosis in diabetic nephropathy. | Nat Rev Nephrol | 2016 | https://conductscience.org/library/papers/26898629 | PubMed |
| 12 | 19165215 | Biogenesis of small RNAs in animals. | Nat Rev Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19165215 | PubMed |
| 13 | 25750628 | MicroRNAs in renal fibrosis. | Front Physiol | 2015 | https://conductscience.org/library/papers/25750628 | PubMed |
| 14 | 18955434 | Most mammalian mRNAs are conserved targets of microRNAs. | Genome Res | 2009 | https://conductscience.org/library/papers/18955434 | PubMed |
| 15 | 34522205 | Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. | Theranostics | 2021 | https://conductscience.org/library/papers/34522205 | PubMed |
| 16 | 19351599 | MicroRNA-221 regulates high glucose-induced endothelial dysfunction. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19351599 | PubMed |
| 17 | 29127220 | Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD. | Physiol Genomics | 2018 | https://conductscience.org/library/papers/29127220 | PubMed |
| 18 | 39309435 | MicroRNA-29b Plays a Vital Role in Podocyte Injury and Glomerular Diseases through Inducing Mitochondrial Dysfunction. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/39309435 | PubMed |
| 19 | 31702814 | Effects of microRNA‑217 on high glucose‑induced inflammation and apoptosis of human retinal pigment epithelial cells (ARPE‑19) and its underlying mechanism. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/31702814 | PubMed |
| 20 | 36675311 | MicroRNAs Associated with Chronic Kidney Disease in the General Population and High-Risk Subgroups-A Systematic Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675311 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958439 | Inflammatory networks between adipose tissue, liver and pancreatic islets in type 2 diabetes. | Hum Genomics | 2026 | https://conductscience.org/library/papers/42958439 | PubMed |
| 42939514 | Fully Complementary Interactions of Human mRNA Genes with miRNAs from NCBI Database. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939514 | PubMed |
| 42930010 | Advanced Therapies for Diabetic Kidney Disease: A Critical Review of Gene-, RNA-, and Cell-Based Strategies to Address Residual Risk. | Diseases | 2026 | https://conductscience.org/library/papers/42930010 | PubMed |
| 42846585 | Novel applications of SIRT1 in Chronic Kidney Disease. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42846585 | PubMed |
| 42783420 | Targeting MicroRNA-21 in Chronic Kidney Disease: Lessons from the Lademirsen Story. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42783420 | PubMed |
| 42506451 | Extracellular Vesicle-Associated microRNAs as Candidate Biomarkers and Mediators of Diabetic Complications: Clinical and Translational Evidence Across Neuropathy, Diabetic Kidney Disease, Retinopathy, and MASLD. | Metabolites | 2026 | https://conductscience.org/library/papers/42506451 | PubMed |
| 42353293 | Extracellular Vesicle-Derived MicroRNAs as Early Diagnostic Biomarkers of Diabetic Nephropathy and Cardiovascular Diseases in Type 2 Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353293 | PubMed |
| 42343466 | Silymarin attenuates diabetic nephropathy in rats via modulation of the miRNA-223/NLRP3/caspase-1/GSDMD axis and inflammasome-related pyroptotic signaling. | Biol Direct | 2026 | https://conductscience.org/library/papers/42343466 | PubMed |
| 42100367 | Translational insights into miR-126 and miR-423: biomarkers and therapeutic targets in cancer, cardiovascular, metabolic and kidney diseases. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42100367 | PubMed |
| 42041569 | The Role of Non-Coding RNA in the Pathogenesis of Hypertensive Nephropathy. | Cells | 2026 | https://conductscience.org/library/papers/42041569 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR192 | 406967 | PubTator's text mining | https://conductscience.org/library/genes/406967 | NCBI Gene |
| MIR21 | 406991 | PubTator's text mining | https://conductscience.org/library/genes/406991 | NCBI Gene |
| MIR214 | 406996 | PubTator's text mining | https://conductscience.org/library/genes/406996 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41516293
GET https://conductscience.org/api/papers/v1/41516293/references?page=2